Marker Therapeutics Stock Market Value
| MRKR Stock | USD 3.52 0.08 2.33% |
| Symbol | Marker |
Marker Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marker Therapeutics. If investors know Marker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marker Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.07) | Revenue Per Share 0.42 | Quarterly Revenue Growth 0.533 | Return On Assets (0.41) | Return On Equity (0.72) |
The market value of Marker Therapeutics is measured differently than its book value, which is the value of Marker that is recorded on the company's balance sheet. Investors also form their own opinion of Marker Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Marker Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marker Therapeutics' market value can be influenced by many factors that don't directly affect Marker Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marker Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marker Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marker Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Marker Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Marker Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Marker Therapeutics.
| 09/05/2024 |
| 12/04/2024 |
If you would invest 0.00 in Marker Therapeutics on September 5, 2024 and sell it all today you would earn a total of 0.00 from holding Marker Therapeutics or generate 0.0% return on investment in Marker Therapeutics over 90 days. Marker Therapeutics is related to or competes with Lumos Pharma, Exicure, Protagenic Therapeutics, Pmv Pharmaceuticals, Anebulo Pharmaceuticals, Bionomics, and Agenus. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of... More
Marker Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Marker Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Marker Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.22 | |||
| Information Ratio | 0.0277 | |||
| Maximum Drawdown | 37.38 | |||
| Value At Risk | (11.56) | |||
| Potential Upside | 9.72 |
Marker Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Marker Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Marker Therapeutics' standard deviation. In reality, there are many statistical measures that can use Marker Therapeutics historical prices to predict the future Marker Therapeutics' volatility.| Risk Adjusted Performance | 0.0419 | |||
| Jensen Alpha | 0.3772 | |||
| Total Risk Alpha | (0.69) | |||
| Sortino Ratio | 0.0326 | |||
| Treynor Ratio | (0.45) |
Marker Therapeutics Backtested Returns
Marker Therapeutics appears to be slightly risky, given 3 months investment horizon. Marker Therapeutics has Sharpe Ratio of 0.0596, which conveys that the firm had a 0.0596% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Marker Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Marker Therapeutics' Risk Adjusted Performance of 0.0419, mean deviation of 5.45, and Downside Deviation of 6.22 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Marker Therapeutics holds a performance score of 4. The company secures a Beta (Market Risk) of -0.69, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Marker Therapeutics are expected to decrease at a much lower rate. During the bear market, Marker Therapeutics is likely to outperform the market. Please check Marker Therapeutics' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Marker Therapeutics' current price movements will revert.
Auto-correlation | 0.03 |
Virtually no predictability
Marker Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Marker Therapeutics time series from 5th of September 2024 to 20th of October 2024 and 20th of October 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Marker Therapeutics price movement. The serial correlation of 0.03 indicates that only 3.0% of current Marker Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Marker Therapeutics lagged returns against current returns
Autocorrelation, which is Marker Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Marker Therapeutics' stock expected returns. We can calculate the autocorrelation of Marker Therapeutics returns to help us make a trade decision. For example, suppose you find that Marker Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Marker Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Marker Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Marker Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Marker Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Marker Therapeutics Lagged Returns
When evaluating Marker Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Marker Therapeutics stock have on its future price. Marker Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Marker Therapeutics autocorrelation shows the relationship between Marker Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Marker Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Marker Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Marker Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Marker Stock
The ability to find closely correlated positions to Marker Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marker Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marker Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marker Therapeutics to buy it.
The correlation of Marker Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marker Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marker Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marker Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.